Targeted therapy could turn advanced lung cancer into chronic illness: CUHK study
--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-06-10 18:03 UTC+10:00
Section: brain metastases
Factuality Score: 100
Opinion Category: Neutral
Topics: Science, Health, Law & Courts, World News, Environment & Climate, Crime & Justice
--------------------------------------------------------------------
Snippet:
Clinical trial finds 55 per cent of patients on lorlatinib experience no disease progression for at least seven years
--------------------------------------------------------------------